Cambrosio et al. (2018. “Extending Experimentation: Oncology’s Fading Boundary Between Research and Care.” New Genetics and Society 37 (3): 207–226) argue that “experimental care” in contemporary oncology involves the rapid merging of patient research and care, and invite further study into developments across other health conditions. We present a 2018–2019 study of experimental breast cancer care in an urban clinical setting in the light of two other studies in the same hospital group: in the same cancer service (2013–14) and, prompted by these earlier findings, an interview study in HIV services (2014–15). We found that patients and staff anticipated better outcomes by treating sub-types of breast cancer but they also hoped for a better one-size-fits-all approach, akin to the antiretroviral treatments introduced for HIV and explored in our interview study. We conclude that the promise of targeted treatment for sub-types of disease – variously described as experimental care, personalised, precision, stratified and sub-group medicine – is accompanied by hopes for a single, standard, effective approach.

坎布罗西奥等人。（2018 年。“扩展实验：研究和护理之间的肿瘤学逐渐消失的边界。”新遗传学与社会37 (3): 207-226) 认为当代肿瘤学中的“实验性护理”涉及患者研究和护理的快速合并，并邀请进一步研究其他健康状况的发展。根据同一医院组的其他两项研究，我们展示了 2018-2019 年在城市临床环境中进行的实验性乳腺癌护理研究：在同一癌症服务中（2013-14 年），并根据这些早期发现，进行了一次采访艾滋病服务研究（2014-15）。我们发现，患者和工作人员预期通过治疗亚型乳腺癌获得更好的结果，但他们也希望有一种更好的一刀切的方法，类似于针对 HIV 引入的抗逆转录病毒治疗，并在我们的访谈研究中进行了探讨。我们得出的结论是，针对亚型疾病的靶向治疗的前景 - 不同地描述为实验性护理，